Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07739680
EFFECTS OF HIPPOTHERAPY IN CHILDREN WITH CEREBRAL PALSYFenerbahce UniversityNot Yet RecruitingNot Applicable
NCT07739680Not Yet Recruiting
Not Applicable
EFFECTS OF HIPPOTHERAPY IN CHILDREN WITH CEREBRAL PALSYFenerbahce University
NCT07738562
Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological EffectsHadassah Medical OrganizationNot Yet RecruitingPhase 1
NCT07738562Not Yet Recruiting
Phase 1
Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmac...Hadassah Medical Organiza...
NCT07738783
Ultrasound-Guided Dry Needling, Lidocaine Injection, and Oxygen-Ozone Therapy for Myofascial Pain SyndromeDerince Training and Research HospitalCompletedNot Applicable
NCT07738783Completed
Not Applicable
Ultrasound-Guided Dry Needling, Lidocaine Injection, and Oxygen-Ozone Therapy fo...Derince Training and Rese...
NCT07738341
GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)Eddingpharm (Zhuhai) Co., Ltd.Not Yet RecruitingPhase 1
NCT07738341Not Yet Recruiting
Phase 1
GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast...Eddingpharm (Zhuhai) Co.,...
NCT07738614
A Study of Eloralintide (LY3841136) in Participants With Obesity or OverweightEli Lilly and CompanyNot Yet RecruitingPhase 1
NCT07738614Not Yet Recruiting
Phase 1
A Study of Eloralintide (LY3841136) in Participants With Obesity or OverweightEli Lilly and Company
NCT07739524
Iron Status Assessment in Geriatric ElderlyCentre Hospitalier Régional d'OrléansNot Yet Recruiting
NCT07739524Not Yet Recruiting
—
Iron Status Assessment in Geriatric ElderlyCentre Hospitalier Région...
NCT07739160
The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke PatientsBeijing Suncadia Pharmaceuticals Co., LtdNot Yet RecruitingPhase 2
NCT07739160Not Yet Recruiting
Phase 2
The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke PatientsBeijing Suncadia Pharmace...
NCT07738939
IKS04 Regimen in Advanced Solid Tumors That Express CA242Iksuda Therapeutics Ltd.Not Yet RecruitingPhase 1
NCT07738939Not Yet Recruiting
Phase 1
IKS04 Regimen in Advanced Solid Tumors That Express CA242Iksuda Therapeutics Ltd.
NCT07738224
Using the Babble Boot Camp© Speech Therapy Approach With Babies Born PrematurelyMurdoch Childrens Research InstituteNot Yet RecruitingNot Applicable
NCT07738224Not Yet Recruiting
Not Applicable
Using the Babble Boot Camp© Speech Therapy Approach With Babies Born PrematurelyMurdoch Childrens Researc...
NCT07738523
Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB TrialHospital Universitario GetafeRecruitingPhase 2
NCT07738523Recruiting
Phase 2
Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFI...Hospital Universitario Ge...
NCT07740330
Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass SurgeryClinique Saint-LucNot Yet RecruitingPhase 4
NCT07740330Not Yet Recruiting
Phase 4
Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surge...Clinique Saint-Luc
NCT07738887
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 AlterationsAbbVieNot Yet RecruitingPhase 2
NCT07738887Not Yet Recruiting
Phase 2
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic...AbbVie
NCT07739186
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739186Not Yet Recruiting
Phase 2
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody...Baili-Bio (Chengdu) Pharm...
NCT07738835
Early Addiction Care Pathway After Acute Drug Intoxication in Emergency DepartmentsAssistance Publique - Hôpitaux de ParisNot Yet RecruitingNot Applicable
NCT07738835Not Yet Recruiting
Not Applicable
Early Addiction Care Pathway After Acute Drug Intoxication in Emergency Departme...Assistance Publique - Hôp...
NCT07740317
Neurocognitive Trajectories After BCMA CAR-TAtrium Health Wake Forest BaptistNot Yet Recruiting
NCT07740317Not Yet Recruiting
—
Neurocognitive Trajectories After BCMA CAR-TAtrium Health Wake Forest...
NCT07740421
A Prospective, Multicenter, Phase III Clinical Evaluation of the Safety and Efficacy of NH002 as a Contrast Agent Administrated Via Intravenous Bolus Injection and Infusion for Subjects Undergoing Cardiac EchocardiographySyneos HealthNot Yet RecruitingPhase 3
NCT07740421Not Yet Recruiting
Phase 3
A Prospective, Multicenter, Phase III Clinical Evaluation of the Safety and Effi...Syneos Health
NCT07740369
An Exploration of Family Centred Care (FCC) in UK Inpatient WardsMilton Keynes University Hospital NHS Foundation TrustRecruiting
NCT07740369Recruiting
—
An Exploration of Family Centred Care (FCC) in UK Inpatient WardsMilton Keynes University...
NCT07740629
Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety?Yair DaykanNot Yet RecruitingNot Applicable
NCT07740629Not Yet Recruiting
Not Applicable
Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anx...Yair Daykan
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07740044
Medical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Chronic Disease ManagementJiangsu Taizhou People's HospitalNot Yet RecruitingNot Applicable
NCT07740044Not Yet Recruiting
Not Applicable
Medical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Ch...Jiangsu Taizhou People's...
Result Breakdown
Not yet recruiting16 (80%)
Completed2 (10%)
Recruiting2 (10%)
not_applicable7 (35%)
Phase 14 (20%)
Phase 24 (20%)
Not Specified3 (15%)
Phase 41 (5%)
Phase 31 (5%)